Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Heilig

Showing results (161-170 of 172) with videos related to

Pageof 18
Sort By:
The New England Journal of Medicine|February 26, 2010
An algorithm for tuberculosis screening and diagnosis in people with HIVKevin P Cain, Kimberly D McCarthy, Charles M Heilig, et al.
The Journal of Infectious Diseases|August 2, 2012
Substitution of rifapentine for rifampin during intensive phase treatment of pulmonary tuberculosis: study 29 of the tuberculosis trials consortiumSusan E Dorman, Stefan Goldberg, Jason E Stout, et al.
Scientific Reports|December 27, 2024
Principal component analysis of the Serological response to Plasmodium Falciparum using a Multiplex bead-based assay in NigeriaJonathan S Schultz, Mary Okoli, Scott Lee, et al.
JAMA Pediatrics|February 22, 2021
Sensitive and Feasible Specimen Collection and Testing Strategies for Diagnosing Tuberculosis in Young ChildrenRinn Song, Eleanor S Click, Kimberly D McCarthy, et al.
American Journal of Respiratory and Critical Care Medicine|May 2, 2009
Substitution of moxifloxacin for isoniazid during intensive phase treatment of pulmonary tuberculosisSusan E Dorman, John L Johnson, Stefan Goldberg, et al.
Contemporary Clinical Trials|April 1, 2021
Optimizing drug inventory management with a web-based information system: The TBTC Study 31/ACTG A5349 experienceNigel A Scott, Kara K Lee, Claire Sadowski, et al.
American Journal of Respiratory and Critical Care Medicine|December 10, 2014
Daily rifapentine for treatment of pulmonary tuberculosis. A randomized, dose-ranging trialSusan E Dorman, Radojka M Savic, Stefan Goldberg, et al.
Hepatology (Baltimore, Md.)|March 25, 2000
Genetic polymorphism of alcohol dehydrogenase in europeans: the ADH2*2 allele decreases the risk for alcoholism and is associated with ADH3*1E Borràs, C Coutelle, A Rosell, et al.
Physical Review Letters|April 28, 2023
Measurement of the α-Particle Monopole Transition Form Factor Challenges Theory: A Low-Energy Puzzle for Nuclear Forces?S Kegel, P Achenbach, S Bacca, et al.
Contemporary Clinical Trials|January 26, 2020
High-dose rifapentine with or without moxifloxacin for shortening treatment of pulmonary tuberculosis: Study protocol for TBTC study 31/ACTG A5349 phase 3 clinical trialSusan E Dorman, Payam Nahid, Ekaterina V Kurbatova, et al.
Pageof 18

Showing results (161-170 of 172) with videos related to

Sort By:
Pageof 18
The New England Journal of Medicine|February 26, 2010
An algorithm for tuberculosis screening and diagnosis in people with HIVKevin P Cain, Kimberly D McCarthy, Charles M Heilig, et al.
The Journal of Infectious Diseases|August 2, 2012
Substitution of rifapentine for rifampin during intensive phase treatment of pulmonary tuberculosis: study 29 of the tuberculosis trials consortiumSusan E Dorman, Stefan Goldberg, Jason E Stout, et al.
Scientific Reports|December 27, 2024
Principal component analysis of the Serological response to Plasmodium Falciparum using a Multiplex bead-based assay in NigeriaJonathan S Schultz, Mary Okoli, Scott Lee, et al.
JAMA Pediatrics|February 22, 2021
Sensitive and Feasible Specimen Collection and Testing Strategies for Diagnosing Tuberculosis in Young ChildrenRinn Song, Eleanor S Click, Kimberly D McCarthy, et al.
American Journal of Respiratory and Critical Care Medicine|May 2, 2009
Substitution of moxifloxacin for isoniazid during intensive phase treatment of pulmonary tuberculosisSusan E Dorman, John L Johnson, Stefan Goldberg, et al.
Contemporary Clinical Trials|April 1, 2021
Optimizing drug inventory management with a web-based information system: The TBTC Study 31/ACTG A5349 experienceNigel A Scott, Kara K Lee, Claire Sadowski, et al.
American Journal of Respiratory and Critical Care Medicine|December 10, 2014
Daily rifapentine for treatment of pulmonary tuberculosis. A randomized, dose-ranging trialSusan E Dorman, Radojka M Savic, Stefan Goldberg, et al.
Hepatology (Baltimore, Md.)|March 25, 2000
Genetic polymorphism of alcohol dehydrogenase in europeans: the ADH2*2 allele decreases the risk for alcoholism and is associated with ADH3*1E Borràs, C Coutelle, A Rosell, et al.
Physical Review Letters|April 28, 2023
Measurement of the α-Particle Monopole Transition Form Factor Challenges Theory: A Low-Energy Puzzle for Nuclear Forces?S Kegel, P Achenbach, S Bacca, et al.
Contemporary Clinical Trials|January 26, 2020
High-dose rifapentine with or without moxifloxacin for shortening treatment of pulmonary tuberculosis: Study protocol for TBTC study 31/ACTG A5349 phase 3 clinical trialSusan E Dorman, Payam Nahid, Ekaterina V Kurbatova, et al.
Pageof 18